HSPB1 and lung adenocarcinoma: Because, HSP27 overexpression showed reduced patient survival in lung adenocarcinoma, according to at least one publically available clinicogenomics database (Figure 6A), we next examined whether altered cross-linking of HSP27 by SW15 affected HSP27-mediated resistance after treatment with conventional anticancer modalities.